Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Brain Neoplasms, Adult, Malignant: later-stage trial registry
2 of 3 indexed Brain Neoplasms, Adult, Malignant trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Brain Neoplasms, Adult, Malignant: 3 US clinical trials tracked, 2 recruiting.
Brain Neoplasms, Adult, Malignant is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Ivy Brain Tumor Center, running 1 of these trials.
Enrollment posture brief
Registry condition brain-neoplasms-adult-malignant
OPEN 2 | RECR 67% | LATE 1 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Brain Neoplasms, Adult, Malignant lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Brain Neoplasms, Adult, Malignant on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Brain Neoplasms, Adult, Malignant is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma
Ivy Brain Tumor Center
NCT06388733
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
Erasmus Medical Center
NCT06273176
Stereotactic Radiosurgery (SRS) Dose-Escalation Study for Brain Metastasis
University of Texas Southwestern Medical Center
NCT02645487
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Brain Neoplasms, Adult, Malignant records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Brain Neoplasms, Adult, Malignant trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Brain Neoplasms, Adult, Malignant page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Brain Neoplasms, Adult, Malignant trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Ivy Brain Tumor Center sponsors the most Brain Neoplasms, Adult, Malignant trials on record, review their full trial history before evaluating a specific study. See Ivy Brain Tumor Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Brain Neoplasms, Adult, Malignant condition card totals 3 registered trials; most-linked intervention Resection under general anesthesia without mapping; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.